a Phase 2a clinical trial in patients with Mycobacterium abscessus pulmonary disease.
Latest Information Update: 16 Feb 2026
At a glance
- Drugs MRX 5 (Primary)
- Indications Nontuberculous mycobacterium infections
- Focus Therapeutic Use
Most Recent Events
- 16 Feb 2026 New trial record